Literature DB >> 27638338

Nucleic acid-mediated autoinflammation and autoimmunity-type I interferonopathies.

Min Ae Lee-Kirsch1, Claudia Günther2, Axel Roers3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27638338     DOI： 10.1007/s00109-016-1467-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  30 in total

1.  Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome.

Authors:  Mi-Ae Jang; Eun Kyoung Kim; Hesung Now; Nhung T H Nguyen; Woo-Jong Kim; Joo-Yeon Yoo; Jinhyuk Lee; Yun-Mi Jeong; Cheol-Hee Kim; Ok-Hwa Kim; Seongsoo Sohn; Seong-Hyeuk Nam; Yoojin Hong; Yong Seok Lee; Sung-A Chang; Shin Yi Jang; Jong-Won Kim; Myung-Shik Lee; So Young Lim; Ki-Sun Sung; Ki-Tae Park; Byoung Joon Kim; Joo-Heung Lee; Duk-Kyung Kim; Changwon Kee; Chang-Seok Ki
Journal:  Am J Hum Genet       Date:  2015-01-22       Impact factor: 11.025

Review 2.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

Review 3.  Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.

Authors:  Hanna Kim; Gina A Montealegre Sanchez; Raphaela Goldbach-Mansky
Journal:  J Mol Med (Berl)       Date:  2016-09-27       Impact factor: 4.599

4.  Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.

Authors:  Anja Brehm; Yin Liu; Afzal Sheikh; Bernadette Marrero; Ebun Omoyinmi; Qing Zhou; Gina Montealegre; Angelique Biancotto; Adam Reinhardt; Adriana Almeida de Jesus; Martin Pelletier; Wanxia L Tsai; Elaine F Remmers; Lela Kardava; Suvimol Hill; Hanna Kim; Helen J Lachmann; Andre Megarbane; Jae Jin Chae; Jilian Brady; Rhina D Castillo; Diane Brown; Angel Vera Casano; Ling Gao; Dawn Chapelle; Yan Huang; Deborah Stone; Yongqing Chen; Franziska Sotzny; Chyi-Chia Richard Lee; Daniel L Kastner; Antonio Torrelo; Abraham Zlotogorski; Susan Moir; Massimo Gadina; Phil McCoy; Robert Wesley; Kristina I Rother; Kristina Rother; Peter W Hildebrand; Paul Brogan; Elke Krüger; Ivona Aksentijevich; Raphaela Goldbach-Mansky
Journal:  J Clin Invest       Date:  2015-10-20       Impact factor: 14.808

5.  Trex1 prevents cell-intrinsic initiation of autoimmunity.

Authors:  Daniel B Stetson; Joan S Ko; Thierry Heidmann; Ruslan Medzhitov
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

6.  Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity.

Authors:  Bjoern Hiller; Martin Achleitner; Silke Glage; Ronald Naumann; Rayk Behrendt; Axel Roers
Journal:  J Exp Med       Date:  2012-07-16       Impact factor: 14.307

7.  SAMHD1 prevents autoimmunity by maintaining genome stability.

Authors:  Stefanie Kretschmer; Christine Wolf; Nadja König; Wolfgang Staroske; Jochen Guck; Martin Häusler; Hella Luksch; Laura A Nguyen; Baek Kim; Dimitra Alexopoulou; Andreas Dahl; Alexander Rapp; M Cristina Cardoso; Anna Shevchenko; Min Ae Lee-Kirsch
Journal:  Ann Rheum Dis       Date:  2014-01-20       Impact factor: 19.103

8.  Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome.

Authors:  Marije E C Meuwissen; Rachel Schot; Sofija Buta; Grétel Oudesluijs; Sigrid Tinschert; Scott D Speer; Zhi Li; Leontine van Unen; Daphne Heijsman; Tobias Goldmann; Maarten H Lequin; Johan M Kros; Wendy Stam; Mark Hermann; Rob Willemsen; Rutger W W Brouwer; Wilfred F J Van IJcken; Marta Martin-Fernandez; Irenaeus de Coo; Jeroen Dudink; Femke A T de Vries; Aida Bertoli Avella; Marco Prinz; Yanick J Crow; Frans W Verheijen; Sandra Pellegrini; Dusan Bogunovic; Grazia M S Mancini
Journal:  J Exp Med       Date:  2016-06-20       Impact factor: 14.307

Review 9.  Cause and consequences of the activated type I interferon system in SLE.

Authors:  Maija-Leena Eloranta; Lars Rönnblom
Journal:  J Mol Med (Berl)       Date:  2016-04-20       Impact factor: 4.599

10.  Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation.

Authors:  Xianqin Zhang; Dusan Bogunovic; Béatrice Payelle-Brogard; Véronique Francois-Newton; Scott D Speer; Chao Yuan; Stefano Volpi; Zhi Li; Ozden Sanal; Davood Mansouri; Ilhan Tezcan; Gillian I Rice; Chunyuan Chen; Nahal Mansouri; Seyed Alireza Mahdaviani; Yuval Itan; Bertrand Boisson; Satoshi Okada; Lu Zeng; Xing Wang; Hui Jiang; Wenqiang Liu; Tiantian Han; Delin Liu; Tao Ma; Bo Wang; Mugen Liu; Jing-Yu Liu; Qing K Wang; Dilek Yalnizoglu; Lilliana Radoshevich; Gilles Uzé; Philippe Gros; Flore Rozenberg; Shen-Ying Zhang; Emmanuelle Jouanguy; Jacinta Bustamante; Adolfo García-Sastre; Laurent Abel; Pierre Lebon; Luigi D Notarangelo; Yanick J Crow; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Sandra Pellegrini
Journal:  Nature       Date:  2014-10-12       Impact factor: 49.962
View more
  2 in total

1.  Autoimmunity gene IRGM suppresses cGAS-STING and RIG-I-MAVS signaling to control interferon response.

Authors:  Kautilya Kumar Jena; Subhash Mehto; Parej Nath; Nishant Ranjan Chauhan; Rinku Sahu; Kollori Dhar; Saroj Kumar Das; Srinivasa Prasad Kolapalli; Krushna C Murmu; Ashish Jain; Sivaram Krishna; Bhabani Sankar Sahoo; Soma Chattopadhyay; Tor Erik Rusten; Punit Prasad; Swati Chauhan; Santosh Chauhan
Journal:  EMBO Rep       Date:  2020-07-27       Impact factor: 9.071

Review 2.  Type I Interferon Induction in Cutaneous DNA Damage Syndromes.

Authors:  Benjamin Klein; Claudia Günther
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.